Dermatology clinical trials recruiting in Pennsylvania

37 recruiting dermatology trials match in Pennsylvania. Showing 20.

• A Study to Learn About Study Medicine Called PF-08049820 in People With EczemaRecruiting

  Phase 2 · Pfizer · Pittsburgh, Pennsylvania

• A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic DermatitisRecruiting

  Phase 2 · Apogee Therapeutics, Inc. · Pittsburgh, Pennsylvania

• FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and PatientsRecruiting

  Phase 1 · Pfizer · Philadelphia, Pennsylvania

• Study of SFA002 in Patients with Mild to Moderate Psoriasis PlaquesRecruiting

  Phase 1 · SFA Therapeutics · Philadelphia, Pennsylvania

• A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic DermatitisRecruiting

  Phase 2 · Apollo Therapeutics Ltd · Camp Hill, Pennsylvania

• The Impact of Botox on Neuroimmune Interactions in Atopic DermatitisRecruiting

  Phase 1 · Daniel Kaplan · Pittsburgh, Pennsylvania

• A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque PsoriasisRecruiting

  Phase 2 · InventisBio Co., Ltd · Birmingham, Alabama

• A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar PustulosisRecruiting

  Phase 2 · LEO Pharma · Philadelphia, Pennsylvania

• A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in AdultsRecruiting

  Phase 1 · UCB Biopharma SRL · Duncansville, Pennsylvania

• A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic DermatitisRecruiting

  Phase 2 · Hoffmann-La Roche · Camp Hill, Pennsylvania

• A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic ArthritisRecruiting

  Phase 3 · Janssen Research & Development, LLC · Duncansville, Pennsylvania

• Guselkumab vs Golimumab in PsA TNF Inadequate Responder PatientsRecruiting

  Phase 3 · University of Pennsylvania · Philadelphia, Pennsylvania

• Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis SuppurativaRecruiting

  Phase 2 · Incyte Corporation · Danville, Pennsylvania

• A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque PsoriasisRecruiting

  Phase 3 · Bristol-Myers Squibb · Philadelphia, Pennsylvania

• A Study Evaluating BFB759 in Moderate to Severe Hidradenitis SuppurativaRecruiting

  Phase 2 / Phase 3 · Bluefin Biomedicine, Inc. · Pittsburgh, Pennsylvania

• A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesRecruiting

  Phase 3 · Takeda · Duncansville, Pennsylvania

• Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & AdultsRecruiting

  N/A · Galderma R&D · Phoenix, Arizona

• Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)Recruiting

  Phase 2 · Merck Sharp & Dohme LLC · Duncansville, Pennsylvania

• A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic DermatitisRecruiting

  Phase 1 · Brexogen Inc. · Camp Hill, Pennsylvania

• A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic MedicinesRecruiting

  Phase 3 · Takeda · Wyomissing, Pennsylvania

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.